All lobbying filings

INDIVIOR INC

Lobbying for INDIVIOR INC

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $230,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 6

HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 27
HALT Fentanyl Act
HR 2586
Reentry Act of 2025
HR 1510
Due Process Continuity of Care Act
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…

Lobbying activity 1

Health Issues

SUPPORT for Patients and Communities Reauthorization Act (HR 2483); HALT Fentanyl Act (HR 27 / S 331); Reentry Act (HR 2586); Due Process Continuity of Care Act (HR 1510); FY25 and 26 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice Science; FY25 Continuing appropriations (HR 1968); FY26 budget resolution (H Con Res 14); DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.